Our Scorecard ranks every state’s health care system based on how well it provides high-quality, accessible, and equitable health care. Read the report to see health care rankings by state.

Drug pricing reform

Search content about
Drug pricing reform

shot of a Portland, Oregon street with a big Portland sign on a theater.

Controlling Health Care Costs

Oregon Seeks to Limit Medicaid Coverage of Accelerated-Approval Drugs

Blog / Apr 05, 2022

Photos of generic drug bottles from the top

Controlling Health Care Costs

Generic Drugs Help Hold Down Costs, But Slowdowns in Development and Review Present Challenges

Blog / Mar 24, 2022

illustration of patients staring at giant dollar sign

Controlling Health Care Costs

It’s the Patents, Stupid — Why Drugs Cost So Much in the U.S.

Podcast / Feb 25, 2022

Controlling Health Care Costs

State Strategies for Slowing Health Care Cost Growth in the Commercial Market

Issue Briefs / Feb 24, 2022

Aerial view of brightly colored pill boxes for days of the week open with pills in each box

Controlling Health Care Costs

Brand-Name Drug Prices: The Key Driver of High Pharmaceutical Spending in the U.S.

Publication / Nov 17, 2021

Controlling Health Care Costs

Supreme Court Will Determine Whether 340B Hospitals Retain Discounts on Medicare Part B Drugs

Blog / Nov 11, 2021

Controlling Health Care Costs

Domestic Reference Pricing and Its Potential Role in Medicare Pharmaceutical Price Negotiations

Explainer / Oct 26, 2021

pills in pill packets on a white background

Controlling Health Care Costs

Skinny Labeling: A Pathway for Timely Generic Drug Competition

Blog / Oct 19, 2021

Illustration of a bundle of COVID-19 vaccine vials wrapped in U.S. dollars over a world map

Advancing Health Equity

For Global Vaccine Access, Overhaul the Patent System

Podcast / Oct 08, 2021

Chairwoman Carolyn Maloney (D–N.Y.) delivers her opening statement at a hearing

Controlling Health Care Costs

Policymakers’ Attention Turns to Drug Patents in the Debate on Prices

Blog / Oct 07, 2021

Controlling Health Care Costs

The U.S. Can Lower Drug Prices Without Sacrificing Innovation

Blog / Oct 01, 2021

Woman in mask and hat walks outside of CVS pharmacy in parking lot

Controlling Health Care Costs

Medicare Patients Pay More for Drugs Than Older Adults in Other Countries; Congress Has an Opportunity to Move Forward

Blog / Sep 30, 2021

1 2 3 4 5

Advanced Search

Advanced Search

Filter your query

Publication Types

Other

Drug pricing reform

Search content about
Drug pricing reform

Oregon Seeks to Limit Medicaid Coverage of Accelerated-Approval Drugs

Generic Drugs Help Hold Down Costs, But Slowdowns in Development and Review Present Challenges

It’s the Patents, Stupid — Why Drugs Cost So Much in the U.S.

State Strategies for Slowing Health Care Cost Growth in the Commercial Market

Brand-Name Drug Prices: The Key Driver of High Pharmaceutical Spending in the U.S.

Supreme Court Will Determine Whether 340B Hospitals Retain Discounts on Medicare Part B Drugs

Domestic Reference Pricing and Its Potential Role in Medicare Pharmaceutical Price Negotiations

Skinny Labeling: A Pathway for Timely Generic Drug Competition

For Global Vaccine Access, Overhaul the Patent System

Policymakers’ Attention Turns to Drug Patents in the Debate on Prices

The U.S. Can Lower Drug Prices Without Sacrificing Innovation

Medicare Patients Pay More for Drugs Than Older Adults in Other Countries; Congress Has an Opportunity to Move Forward

Publication Types

Other

Drug pricing reform

Search content aboutDrug pricing reform

Search content about
Drug pricing reform